tiprankstipranks
Surgery Partners Inc. (SGRY)
NASDAQ:SGRY
Want to see SGRY full AI Analyst Report?

Surgery Partners (SGRY) Stock Statistics & Valuation Metrics

377 Followers

Total Valuation

Surgery Partners has a market cap or net worth of $1.82B. The enterprise value is $5.64B.
Market Cap$1.82B
Enterprise Value$5.64B

Share Statistics

Surgery Partners has 130,788,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding130,788,160
Owned by Insiders39.86%
Owned by Institutions4.01%

Financial Efficiency

Surgery Partners’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is 4.24%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)4.24%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee220.58K
Profits Per Employee6.59K
Employee Count15,000
Asset Turnover0.40
Inventory Turnover26.33

Valuation Ratios

The current PE Ratio of Surgery Partners is ―. Surgery Partners’s PEG ratio is 0.47.
PE Ratio
PS Ratio0.59
PB Ratio1.15
Price to Fair Value1.15
Price to FCF10.05
Price to Operating Cash Flow6.28
PEG Ratio0.47

Income Statement

In the last 12 months, Surgery Partners had revenue of 3.31B and earned -77.90M in profits. Earnings per share was -0.61.
Revenue3.31B
Gross Profit765.00M
Operating Income389.50M
Pretax Income116.90M
Net Income-77.90M
EBITDA565.50M
Earnings Per Share (EPS)-0.61

Cash Flow

In the last 12 months, operating cash flow was 280.00M and capital expenditures -72.00M, giving a free cash flow of 208.00M billion.
Operating Cash Flow280.00M
Free Cash Flow208.00M
Free Cash Flow per Share1.59

Dividends & Yields

Surgery Partners pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.21
52-Week Price Change-40.99%
50-Day Moving Average13.28
200-Day Moving Average17.19
Relative Strength Index (RSI)46.13
Average Volume (3m)1.44M

Important Dates

Surgery Partners upcoming earnings date is Aug 4, 2026, Before Open (Confirmed).
Last Earnings DateMay 5, 2026
Next Earnings DateAug 4, 2026
Ex-Dividend Date

Financial Position

Surgery Partners as a current ratio of 1.87, with Debt / Equity ratio of 238.63%
Current Ratio1.87
Quick Ratio1.71
Debt to Market Cap1.45
Net Debt to EBITDA6.69
Interest Coverage Ratio1.43

Taxes

In the past 12 months, Surgery Partners has paid 18.00M in taxes.
Income Tax18.00M
Effective Tax Rate0.15

Enterprise Valuation

Surgery Partners EV to EBITDA ratio is 10.17, with an EV/FCF ratio of 29.40.
EV to Sales1.74
EV to EBITDA10.17
EV to Free Cash Flow29.40
EV to Operating Cash Flow20.96

Balance Sheet

Surgery Partners has $182.30M in cash and marketable securities with $4.03B in debt, giving a net cash position of -$3.85B billion.
Cash & Marketable Securities$182.30M
Total Debt$4.03B
Net Cash-$3.85B
Net Cash Per Share-$29.40
Tangible Book Value Per Share-$13.43

Margins

Gross margin is 21.68%, with operating margin of 11.77%, and net profit margin of -2.35%.
Gross Margin21.68%
Operating Margin11.77%
Pretax Margin3.53%
Net Profit Margin-2.35%
EBITDA Margin17.09%
EBIT Margin11.77%

Analyst Forecast

The average price target for Surgery Partners is $19.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$19.75
Price Target Upside41.07% Upside
Analyst ConsensusModerate Buy
Analyst Count11
Revenue Growth Forecast5.38%
EPS Growth Forecast61.15%

Scores

Smart Score1
AI Score